Near-infrared monitoring to guide cooling in newborns
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a special, non-invasive sensor (near-infrared light) to help doctors choose the best cooling treatment for some newborns after brain injury. It may improve how well cooling works and how safely it’s managed in the first week of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born after 33 weeks of pregnancy (gestational age).
- Your baby weighs at least 2.0 kg (about 4.4 pounds).
- You are willing to agree to the study’s extra checks in the first week of life.
- Either your baby is receiving cooling treatment (therapeutic hypothermia) OR your baby has certain signs of brain stress/illness soon after birth.
- Your baby will be able to have an MRI later for follow-up (no implanted devices that make MRI unsafe).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether cooling a newborn’s body can help babies with mild brain injury after a difficult birth. It aims to see if cooling improves brain-related outcomes compared with standard care.
This study looks at the long-term health and development of babies who had a specific brain injury at birth and were treated with whole-body cooling. It may help doctors understand what outcomes to expect years later and how to best support families.
This study uses a special light-based monitor (NIRS) to track blood flow in the brain of premature infants. It compares babies in different conditions related to bleeding, fluid buildup, or other brain fluid changes to help doctors understand what monitoring can show.
This trial studies whether cooling a newborn's body after a difficult birth helps prevent brain damage. Researchers will track babies treated with this cooling therapy and use brain imaging to see how well it works.
This study compares different approaches to “cooling” treatment in newborns with mild hypoxic-ischemic encephalopathy (mild brain injury from not enough oxygen around birth). The goal is to see which approach works best and is safest for babies like yours.
This early study tests whether giving melatonin to newborns with hypoxic-ischemic encephalopathy (brain injury from not enough oxygen around birth) can help protect the brain while they are cooled (therapeutic hypothermia). It may be most relevant if your baby shows early brain-injury signs and meets specific blood test and birth-history timing criteria.
Hear when a new Hypoxic-Ischemic Brain Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.